Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Dec 30:2015:bcr2015209390.
doi: 10.1136/bcr-2015-209390.

Controversy and consent: achieving patient autonomy in thrombolysis for acute submassive pulmonary embolism

Sarah Rachel Pywell  1 , Christopher Daniel Smith  1 , Piero Reynolds  1
Affiliations
Case Reports

Controversy and consent: achieving patient autonomy in thrombolysis for acute submassive pulmonary embolism

Sarah Rachel Pywell et al. BMJ Case Rep. .

Abstract

Acute pulmonary embolism (PE) is associated with a wide variation in patient outcome ranging from completely asymptomatic to cardiac failure and death. This presents a challenge to clinicians in ensuring the correct treatment for individual patients is given and that adverse events secondary to treatment complications are minimised. The evidence for those with massive PEs and non-massive PEs is clear for and against the use of thrombolysis, respectively. However, in those with 'sub-massive' PE there is no clear consensus on whether there is a treatment benefit. We present the case of a patient who presented with a non-haemodynamically significant PE but with evidence of right ventricular dilatation, and discuss the difficulties in treatment decisions in such cases, including the ethical and legal principles of consent, and how clinicians might best allow their patients to make informed decisions when in clinical equipoise.

PubMed Disclaimer

References

    1. Lankeit M, Konstantinides S. Mortality risk assessment and the role of thrombolysis in pulmonary embolism. Crit Care Clin 2011;27:953–67, vii–viii (cited 21 Oct 2014). 10.1016/j.ccc.2011.09.008 - DOI - PubMed
    1. Wells PS, Anderson DR, Rodger M et al. . Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2014;83:416–20 (cited 22 Oct 2014). - PubMed
    1. Jaff MR, McMurtry MS, Archer SL et al. . Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123:1788–830 (cited 10 Jul 2014). 10.1161/CIR.0b013e318214914f - DOI - PubMed
    1. Konstantinides SV, Torbicki A, Agnelli G, et al. , Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033–69, 3069a–3069k doi: 10.1093/eurheartj/ehu283 - PubMed
    1. Laporte S, Mismetti P, Décousus H et al. . Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008;117:1711–16 (cited 22 Oct 2014). 10.1161/CIRCULATIONAHA.107.726232 - DOI - PubMed

Publication types